Abstract:BackgroundDrug-target interaction (DTI) is a vital drug design strategy that plays a significant role in many processes of complex diseases and cellular events. In the face of challenges such as extensive protein data and experimental costs, it is suggested to apply bioinformatics approaches to exploit potential interactions to design new targeted medications. Different data and interaction types bring difficulties to study involving incompatible and heterology formats. The analysis of drug-target interactions in a comprehensive and unified model is a significant challenge.MethodHere, we propose a general method for predicting interactions between small-molecule drugs and protein targets, Large-scale Drug target Screening Convolutional Neural Network (LDS-CNN), which used unified encoding to achieve the calculation of the different data formats in an integrated model to realize feature abstraction and potential object prediction.ResultOn 898,412 interaction data involving 1683 small-molecule compounds and 14,350 human proteins from 8.8 billion records, the proposed method achieved an area under the curve (AUC) of 0.96, an area under the precision-recall curve (AUPRC) of 0.95, and an accuracy of 90.13%. The experimental results illustrated that the proposed method attained high accuracy on the test set, indicating its high predictive ability in drug-target interaction prediction. LDS-CNN is effective for the prediction of large-scale datasets and datasets composed of data with different formats.ConclusionIn this study, we propose a DTI prediction method to solve the problems of unified encoding of large-scale data in multiple formats. It provides a feasible way to efficiently abstract the features among different types of drug-related data, thus reducing experimental costs and time consumption. The proposed method can be used to identify potential drug targets and candidates for the treatment of complex diseases. This work provides a reference for DTI to process large-scale data and different formats with deep learning methods and provides certain suggestions for future research.

Identification of Drug-Disease Associations Using Information of Molecular Structures and Clinical Symptoms Via Deep Convolutional Neural Network

Predicting Drug−disease Associations Via Sigmoid Kernel-Based Convolutional Neural Networks

A Model For Predicting Drug-Disease Associations Based On Dense Convolutional Attention Network

Prediction of Drug-Disease Associations and Their Effects by Signed Network-Based Nonnegative Matrix Factorization

A Highly Efficient Biomolecular Network Representation Model for Predicting Drug-Disease Associations.

Predicting drug-disease associations by using similarity constrained matrix factorization

LDS-CNN: a deep learning framework for drug-target interactions prediction based on large-scale drug screening

Predicting drug-disease associations by network embedding and biomedical data integration.

Predicting Drug-Disease Associations Through Similarity Network Fusion and Multi-View Feature Projection Representation.

Identification of Chemical–Disease Associations Through Integration of Molecular Fingerprint, Gene Ontology and Pathway Information

Graph-Based Neural Collaborative Filtering Model for Drug-Disease Associations Prediction

Inferring Drug-Disease Associations Based on Known Protein Complexes

Predicting drug-target interactions from drug structure and protein sequence using novel convolutional neural networks

Predicting drug-disease associations based on the known association bipartite network

Drug-Protein-Disease Association Prediction and Drug Repositioning Based on Tensor Decomposition.

Predicting drug-disease associations through layer attention graph convolutional network

A Multi-graph Deep Learning Model for Predicting Drug-Disease Associations.

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

Learning from low-rank multimodal representations for predicting disease-drug associations

WGMFDDA: A Novel Weighted-Based Graph Regularized Matrix Factorization for Predicting Drug-Disease Associations.

Gndd: A Graph Neural Network-Based Method For Drug-Disease Association Prediction